@article {RequenaS34作者= {Manuel Requena Zeguang任和马克·日博},title ={直接转移到Angiosuite急性中风},体积={97}={20补充2},页面= {S34——S41} = {2021}, doi = {10.1212 / WNL。出版商0000000000012799}= {Wolters Kluwer健康,公司代表美国神经病学学会},文摘={时间再灌注是一个最靠谱的功能结果在急性中风由于大血管闭塞(LVO)。首页直接转移到造影术(递延税资产)在减少住院延迟协议表现出令人鼓舞的结果。递延税资产可以绕过传统的成像在急诊室排除颅内出血或大与成像之前执行传输建立了梗塞thrombectomy-capable中心使用平板电脑断层血管摄影套件(FP-CT)。中风患者的代码主要是承认一个综合中风中心建立了大型缺血性病变\ < 10 \ % 6小时内发病,仍然\ < 20 \ %患者LVO或转移从主中风中心。同时,中风的严重程度是可以接受的LVO预测指标。因此,理想的递延税资产候选人承认早期的窗子有严重症状的患者。协议采用不同中心之间的主要区别是包含FP-CT血管摄影证实前LVO股穿刺。虽然一些中心倡导FP-CT血管造影术,其他人支持额外的节省时间的通过直接评估的存在LVO血管造影。然而,后者会导致不必要的动脉穿刺患者没有LVO (3 \ % {\ textendash} 22 \ %根据选择标准)。 Independently of these different imaging protocols, DTAS has been shown to be effective and safe in improving in-hospital workflow, achieving a reduction of door-to-puncture time as low as 16 minutes without safety concerns. The impact of DTAS on long-term functional outcomes varies between published studies, and randomized controlled trials are warranted to examine the benefit of DTAS.ANGIOCAT=Evaluation of Direct Transfer to Angiography Suite vs. Computed Tomography Suite in Endovascular Treatment: Randomized Clinical Trial; ASPECTS=Alberta Stroke Program Early CT Score; CI=confidence interval; CTA=CT angiography; CTP=CT perfusion; DIRECT-MT=Direct Intra-Arterial Thrombectomy in Order to Revascularize AIS Patients With Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals; DTAS=direct transfer to angiography suite; DTP=door arrival to femoral puncture; EVT=endovascular treatment; FP-CT=flat-panel CT; HERMES=Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke; LVO=large vessel occlusion; MR CLEAN=Multicenter Randomized Clinical Trial of Endovascular Treatment for AIS in the Netherlands; mRS=modified Rankin Scale; MT=mechanical thrombectomy; MVO=medium vessel occlusion; NIHSS=NIH Stroke Scale; OR=odds ratio; OTD=onset to door arrival; RCT=randomized controlled trial; THRACE=Trial and Cost Effectiveness Evaluation of Intra-Arterial Thrombectomy in Acute Ischemic Stroke; tPA=tissue plasminogen activator}, issn = {0028-3878}, URL = {//www.ez-admanager.com/content/97/20_Supplement_2/S34}, eprint = {//www.ez-admanager.com/content/97/20_Supplement_2/S34.full.pdf}, journal = {Neurology} }